Analyst Price Targets — OVV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 11:37 am | — | Roth Capital | $50.00 | $50.83 | TheFly | Ovintiv price target raised to $50 from $42 at Roth Capital |
| February 18, 2026 12:03 pm | — | UBS | $58.00 | $46.08 | TheFly | Ovintiv price target raised to $58 from $55 at UBS |
| January 17, 2026 1:27 pm | Lloyd Byrne | Jefferies | $54.00 | $39.69 | TheFly | Ovintiv price target raised to $54 from $52 at Jefferies |
| December 12, 2025 1:18 pm | — | UBS | $55.00 | $40.76 | TheFly | Ovintiv price target raised to $55 from $54 at UBS |
| November 21, 2025 11:57 am | — | UBS | $54.00 | $38.56 | TheFly | Ovintiv price target raised to $54 from $52 at UBS |
| November 6, 2025 5:28 pm | — | Evercore ISI | $47.00 | $37.59 | TheFly | Ovintiv price target raised to $47 from $43 at Evercore ISI |
| October 15, 2025 9:12 am | Greg Pardy | RBC Capital | $55.00 | $36.81 | TheFly | Ovintiv upgraded to Outperform from Sector Perform at RBC Capital |
| October 14, 2025 2:21 pm | — | Morgan Stanley | $46.00 | $37.41 | TheFly | Ovintiv price target lowered to $46 from $48 at Morgan Stanley |
| October 13, 2025 8:08 pm | — | Roth Capital | $42.00 | $37.99 | TheFly | Ovintiv initiated with a Neutral at Roth Capital |
| October 7, 2025 11:10 am | — | Barclays | $55.00 | $40.07 | TheFly | Ovintiv price target lowered to $55 from $57 at Barclays |
Latest News for OVV
OVV tops Q4 earnings estimates as production climbs, but revenues slip year over year amid weaker oil prices.
Ovintiv Inc. struggles to deliver sustained earnings and shareholder returns post-acquisitions. Recent earnings highlight persistent challenges in translating operational expertise into financial growth. Management plans to return 75% of cash flow to shareholders.
Pre-Market Stock Futures: Futures are trading higher this morning, but what a difference a day makes after a "Meltdown Monday." Stocks rallied on Tuesday, and all major indices closed higher. While not recouping all of the losses from Monday, a strong bounce-back was a welcome sight for investors. A combination of a rebound in technology... Here Are Wednesday's Top Wall Street Analyst Research Calls: AbbVie, Angel…
Ovintiv Inc. (OVV) Q4 2025 Earnings Call Transcript
While the top- and bottom-line numbers for Ovintiv (OVV) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OVV.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.